These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18161821)

  • 1. Study of the micro-structural properties of RISUG--a newly developed male contraceptive.
    Kumar S; Roy S; Chaudhury K; Sen P; Guha SK
    J Biomed Mater Res B Appl Biomater; 2008 Jul; 86(1):154-61. PubMed ID: 18161821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological alterations in human spermatozoa associated with the polyelectrolytic effect of RISUG.
    Kumar S; Chaudhury K; Sen P; Guha SK
    Micron; 2006; 37(6):526-32. PubMed ID: 16504524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RISUG (reversible inhibition of sperm under guidance)--an antimicrobial as male vas deferens implant for HIV free semen.
    Guha SK
    Med Hypotheses; 2005; 65(1):61-4. PubMed ID: 15893119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUG.
    Chaki SP; Das HC; Misro MM
    Contraception; 2003 Jan; 67(1):73-8. PubMed ID: 12521662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical mechanism-mediated time-dependent effect on sperm of human and monkey vas implanted polyelectrolyte contraceptive.
    Guha SK
    Asian J Androl; 2007 Mar; 9(2):221-7. PubMed ID: 17334590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of surface micro-roughness alterations in human spermatozoa using atomic force microscopy.
    Kumar S; Chaudhury K; Sen P; Guha SK
    J Microsc; 2007 Aug; 227(Pt 2):118-23. PubMed ID: 17845707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the membrane integrity of human sperm treated with a new injectable male contraceptive.
    Chaudhury K; Bhattacharyya AK; Guha SK
    Hum Reprod; 2004 Aug; 19(8):1826-30. PubMed ID: 15192063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proton NMR study of the effect of a new intravasal injectable male contraceptive RISUG on seminal plasma metabolites.
    Sharma U; Chaudhury K; Jagannathan NR; Guha SK
    Reproduction; 2001 Sep; 122(3):431-6. PubMed ID: 11597307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative suitability of DMSO and NaHCO3 for reversal of RISUG® induced long-term contraception.
    Ansari AS; Hussain M; Khan SR; Lohiya NK
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety & efficacy of an intravasal, one-time injectable & non-hormonal male contraceptive (RISUG): A clinical experience.
    Sharma RS; Mathur AK; Singh R; Das HC; Singh GJ; Toor DPS; Guha SK
    Indian J Med Res; 2019 Jul; 150(1):81-86. PubMed ID: 31571633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a new injectable male contraceptive on the seminal plasma amino acids studied by proton NMR spectroscopy.
    Chaudhury K; Sharma U; Jagannathan NR; Guha SK
    Contraception; 2002 Sep; 66(3):199-204. PubMed ID: 12384210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives of contraceptive choices for men.
    Lohiya NK; Manivannan B; Bhande SS; Panneerdoss S; Garg S
    Indian J Exp Biol; 2005 Nov; 43(11):1042-7. PubMed ID: 16313067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart RISUG: a potential new contraceptive and its magnetic field-mediated sperm interaction.
    Jha RK; Jha PK; Guha SK
    Int J Nanomedicine; 2009; 4():55-64. PubMed ID: 19421370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyelectrolyte polymer properties in relation to male contraceptive RISUG action.
    Roy S; Ghosh D; Guha SK
    Colloids Surf B Biointerfaces; 2009 Feb; 69(1):77-84. PubMed ID: 19111447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation through genotoxicity and apoptotic markers following RISUG
    Ansari AS; Badar A; Lohiya NK
    Reprod Toxicol; 2018 Oct; 81():84-92. PubMed ID: 30036573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception with RISUG
    Ansari AS; Badar A; Balasubramanian K; Lohiya NK
    Asian J Androl; 2017; 19(4):389-395. PubMed ID: 27586026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genotoxicity in leukocytes and testis following intra-vasal contraception with RISUG and its reversal by DMSO and NaHCO₃ in Wistar albino rats.
    Ansari AS; Alam I; Hussain M; Khan SR; Lohiya NK
    Reprod Toxicol; 2013 Apr; 36():53-9. PubMed ID: 23246611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RISUG: a potential candidate for the entry inhibitor group of antiretroviral drugs.
    Banerjee S; Guha SK
    Med Hypotheses; 2009 Aug; 73(2):150-2. PubMed ID: 19409721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RISUG: an intravasal injectable male contraceptive.
    Lohiya NK; Alam I; Hussain M; Khan SR; Ansari AS
    Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S63-72. PubMed ID: 25673546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible polyvinyl alcohol and RISUG
    Subramanian B; Agarwal T; Ghorai SK; Mandal P; Chattopadhyay S; Basak P; Maiti TK; Guha SK
    Biomed Mater; 2019 Apr; 14(3):035017. PubMed ID: 30726778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.